Related Experiment Video

Updated: Aug 24, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Successful vaccine immunotherapy. An exciting novel approach to cancer treatment

G Daskalakis1, N Thomakos, A Papapanagiotou

  • 1First Department of Obstetrics and Gynaecology, Alexandra Hospital, University of Athens, Athens, Greece.

European Journal of Gynaecological Oncology
|June 3, 2004
PubMed

Insights

Cancer vaccine development is crucial for global health. Early trials show promise with minimal toxicity, paving the way for future advancements in cancer immunotherapy and patient treatment.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Global cancer incidence necessitates enhanced disease surveillance and prevention strategies.
  • Vaccine development is a key area receiving increased resources for cancer control.
  • Understanding tumor antigens is vital for effective cancer vaccine design.

Purpose of the Study:

  • To review the current status and future prospects of cancer vaccine development.
  • To highlight the importance of immunogenic tumor antigens in eliciting anti-cancer immune responses.
  • To discuss the potential of cancer vaccines in inducing tumor regression.

Main Methods:

  • Review of existing phase I/II clinical trial data for cancer vaccines.
  • Analysis of reported patient responses and toxicity profiles.
  • Exploration of basic research on tumor antigens and immune system interactions.

Main Results:

  • Early-phase trials (I/II) have demonstrated partial and complete responses in a subset of patients.
  • Observed toxicity in vaccine recipients has been minimal.
  • A small proportion of individuals showed positive responses to the vaccines.

Conclusions:

  • Cancer vaccines show potential for inducing anti-tumor immunity and tumor regression.
  • Further research into immunogenic tumor antigens is essential for improving vaccine efficacy.
  • Ongoing clinical trials are expected to provide more conclusive evidence on the effectiveness of cancer vaccines in treating malignant diseases.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...